A Review of Research Progress and Clinical Application Scope of Autologous Whole Blood or Autologous Serum Acupoint Injection in the Treatment of Allergic Rhinitis

Allergic rhinitis (AR) is a common chronic inflammatory disorder of the nasal mucosa with high global prevalence, which seriously affects patients’ quality of life. Conventional treatments have certain limitations in long-term application. Autologous whole blood or autologous serum acupoint injection, as a combination of traditional Chinese medicine acupuncture theory and biological therapy, has been increasingly used in clinical practice due to its advantages of good safety and high patient compliance. This paper reviews the recent research progress, mechanism of action, clinical efficacy, and application scope of autologous whole blood or autologous serum acupoint injection in the treatment of allergic rhinitis, and summarizes its clinical indications, administration methods, and safety characteristics. The results show that this therapy can effectively improve nasal symptoms and systemic immune status, and has broad application prospects in the prevention and treatment of allergic rhinitis. At the same time, this paper also analyzes the current problems in standardization and clinical research design, and prospects the future development direction, in order to provide reference for the clinical promotion and further research of this therapy.